��������

Tuan Nguyen has more than 15 years of experience in biopharma working on small molecules and AAV gene therapies. Most recently, he was VP of Finance at Adverum Biotechnologies. Prior to that he held various senior Finance leadership roles at Intarcia Therapeutics, Fibrogen, and UCB. He has helped raise over $1 billion in dilutive and non dilutive capital. Tuan earned his MBA with dual concentration in Finance and Entrepreneurship, Innovation, & Change from Emory University.